Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £17.67m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

Trading update

3 Nov 2022 07:00

RNS Number : 1431F
Insig AI Plc
03 November 2022
 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. It forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

3 November 2022 

 

Insig AI plc

("Insig AI", the "Company" or the "Group")

Trading update

Trading update and revised guidance with profitability now expected from Q2 2023

 

Insig AI plc (AIM:INSG), the data science and machine learning company, today announces a trading update and revised guidance resulting in expected profitability being generated earlier than previously forecast by management.

 

In the Company's final results published on 9 September 2022, the Company stated that a number of contract wins were anticipated to close before the end of October. On 30 September, the Company announced that it had won a contract with a value of £200,000.

 

Two weeks after the publication of the Company's final results, the "mini-budget" took place. As widely reported, this resulted in a sharp rise in borrowing costs, an unprecedented sell-off in UK index-linked government bonds, significant uncertainty and liquidity concerns in the pensions industry. Given Insig AI's focus on the asset management industry, this resulted in a number of our prospects understandably prioritising dealing with the impact on their businesses of sudden market turmoil. As a result of this recent unexpected wave of uncertainty, a number of contracts within our pipeline did not close by 31 October, however, many of these remaining prospects remain active.

 

Over the last 12 months, the Company has invested heavily to build a repository of machine learning ESG company disclosures on more than 2,500 global businesses. Our database now includes constituents of the S&P 500, the STOXX 600 and the FTSE 100/250/350 together with hundreds of non-listed corporates. The Company is confident that this repository can be utilised to deliver a long term revenue stream. Having secured this capability, the Company is now able to flex more of its costs based on orders received. Accordingly, the Board has taken the decision to substantially reduce ongoing costs in relation to the building of the repository of disclosures and the integration of the data filings capabilities.

 

The Board recognises the nascent nature of the ESG space and whilst improved disclosures and an end to greenwashing will be both welcome and inevitable, timings remain uncertain. Having now achieved critical mass within the 'stocks universe' with our repository and the resultant reduction in headcount and other costs noted above, the Board is able to prioritise and accelerate the timeline to expected profitability of the Group. As announced in September 2022, our focus is firmly set on: fintech data science solutions, new fund launches with associated sharing of management fees and selling our ESG proprietary scoring and comparison capabilities to the corporate market.

 

In March 2022, the Company provided revenue targets, which included asset managers as direct buyers of the ESG scoring tool and of data filings. Given the specialised nature of these data filings and our preference to partner with asset managers on new fund launches and fintech data science to generate improved alpha, that to achieve those revenue targets, significant further investment and cost would be required. The Board is therefore reducing these targets and, in turn, any associated costs of investment are now expected to result in an improved return on equity as well as higher operating margins.

 

As previously announced, with the receipt of the R&D tax credit, together with the convertible loan note facilities provided, it was expected that there would be sufficient working capital through to Q2 2023. The Board now believes that no further working capital will be required to support the operations of the business in the short and medium term, as the business is expected to become cash flow positive from Q2 2023 as a result of the cost cutting actions taken. Moreover, the Board also notes as per the announcement on 4 May 2022, the terms of the initial convertible loan note provided by Richard Bernstein stated that the loan was repayable on or before 31 December 2022. Whilst no formal agreement has been made, the Board is in positive discussions with Mr Bernstein to extend this repayment date, however, should the loan become repayable on or before 31 December 2022, the Company would need to raise additional capital.

 

Colm McVeigh, Insig AI's Chief Executive commented: "With recent uncertainty in the asset management and funding markets having increased significantly, we must adapt and accelerate the timing of profitability. Whilst it would have been ideal to have continued to expand our coverage into more smaller companies, the return on this investment would extend beyond our appetite. We prefer to focus on becoming cash positive sooner, which we hope to achieve in Q2 2023."

 

 

For further information, please visit www.insg.ai or contact:  

Insig AI plc

Colm McVeigh (CEO)

  Via SEC Newgate

 

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold / Danny Philips

+44 (0) 20 3829 5000

SEC Newgate (Financial PR)

Robin Tozer / Richard Bicknell

+44 (0) 7540 106 366

insigai@secnewgate.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDGBDBLSGDGDD
Date   Source Headline
1st Jun 20267:00 amRNSEquity subscription raising £0.2m and TVR
30th Apr 20267:00 amRNSNon-executive Directors’ Remuneration in Shares
22nd Apr 20267:00 amRNSEquity Subscription, TVR and PDMR Dealing
20th Apr 20267:00 amRNS-RCentral Bank MCP server in action
13th Apr 20267:00 amRNS-RLaunch of Central Bank Model Context Protocol
7th Apr 20267:01 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSPDMR Dealings
1st Apr 20267:00 amRNSTrading update and potential NASDAQ listing
3rd Mar 20267:00 amRNSInsig AI contract win and revenue share agreement
28th Jan 20267:00 amRNSGrant of Share Options
28th Jan 20267:00 amRNSPDMR Dealing
27th Jan 20267:00 amRNSPDMR Dealing
11th Dec 20257:00 amRNSDirector Dealings
9th Dec 20257:00 amRNSInterim results
10th Nov 20257:00 amRNSNew contract with global advisory firm
29th Oct 20257:00 amRNS-RNew client win: new vertical market breakthrough
27th Oct 20257:00 amRNS-RMelloLondon Investor Event
16th Oct 20253:51 pmRNSResult of AGM
16th Oct 20257:00 amRNSTrading update & extended CLNs and warrant terms
8th Oct 202511:43 amRNSEquity fundraise
7th Oct 20257:00 amRNSEquity fundraise
1st Oct 20257:00 amRNSAppointment of Digital Asset Adviser
22nd Sep 20257:00 amRNSSubscription, Director Dealing & TVR
19th Sep 20257:00 amRNSFinal Results, Posting of AR&A and Notice of AGM
30th Jul 20257:00 amRNS-RLaunch of New Website and Corporate Brand Update
24th Jul 20257:00 amRNSDirector Dealing and Total Voting Rights
3rd Jul 20257:00 amRNSAppointment - Strategic & Asset Allocation Adviser
24th Jun 20257:05 amRNS-RAppointment of Business Development Director
24th Jun 20257:00 amRNSEquity Funding, Subscription, TVR & PDMR Dealing
6th Jun 20257:00 amRNSPDMR Dealings
20th May 20257:00 amRNS-RNew client win and additional sales prospects
12th May 20257:00 amRNS-RMello2025 Investor Event
8th May 20257:00 amRNS-RStrategic client win and new GIE product launch
6th May 20258:00 amRNS-RInsig AI & Falcon Windsor publish research re FTSE
29th Apr 20257:00 amRNSTrading Update and New Client Win
15th Apr 20257:00 amRNSPDMR Dealings
27th Mar 20257:00 amRNSPDMR Dealings
26th Mar 20257:00 amRNSPDMR Dealings
25th Mar 20257:00 amRNSPDMR Dealings
24th Mar 20257:03 amRNSTransfer of Share Options
24th Mar 20257:00 amRNSTrading Update, Equity Subscription, Funding & TVR
13th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20259:21 amRNSReplacement: Change of website address
3rd Mar 20257:00 amRNSChange of website address
17th Feb 20257:00 amRNSNew Client Win and Revenue Share Partnership
19th Dec 20247:00 amRNSInterim Results
22nd Nov 20247:00 amRNSNew business win
11th Oct 20247:00 amRNSDirector Dealing
2nd Oct 202411:14 amRNSPDMR Dealing
30th Sep 20242:41 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.